None
Quote | TearLab Corp - Ordinary Shares (OTCMKTS:TEAR)
Last: | $0.0579 |
---|---|
Change Percent: | 1.49% |
Open: | $0.05705 |
Close: | $0.0579 |
High: | $0.0579 |
Low: | $0.0571 |
Volume: | 20,250 |
Last Trade Date Time: | 07/09/2020 04:55:16 pm |
News | TearLab Corp - Ordinary Shares (OTCMKTS:TEAR)
ESCONDIDO, Calif. , May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which Accelmed Partners II (AP-II) will acquire TearLab. In connection with the acquisiti...
ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (OTCQB: TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions regarding a potential business combination whereby TearLab will be acquired at a ...
Message Board Posts | TearLab Corp - Ordinary Shares (OTCMKTS:TEAR)
Subject | By | Source | When |
---|---|---|---|
$TEAR: Merged with Accelmed Partners II L.P.; $0.0586 | Renee | investorshub | 07/09/2020 1:49:22 PM |
.30 eh -Your DD is probably the worst | Awl416 | investorshub | 05/22/2020 3:54:54 PM |
$TEAR ready to go,read the filling now | ALERTS100%to10000%GAIN | investorshub | 05/22/2020 3:26:58 PM |
better load up, read SCHEDULE 13D ,$TEAR .30 | ALERTS100%to10000%GAIN | investorshub | 05/22/2020 3:26:18 PM |
TEAR .0569,look at the freaking oversold chart and | ALERTS100%to10000%GAIN | investorshub | 05/22/2020 3:14:05 PM |
News, Short Squeeze, Breakout and More Instantly...
TearLab Corp - Ordinary Shares Company Name:
TEAR Stock Symbol:
OTCMKTS Market:
ESCONDIDO, Calif. , May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which Accelmed Partners II (AP-II) will acquire TearLab. In connection with the acquisiti...
ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (OTCQB: TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions regarding a potential business combination whereby TearLab will be acquired at a ...
ESCONDIDO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its 510(k) application for the potential clearan...